Literature DB >> 20426782

Comprehensive analysis of the molecular basis of oculocutaneous albinism in Indian patients lacking a mutation in the tyrosinase gene.

M Sengupta1, M Mondal, P Jaiswal, S Sinha, M Chaki, S Samanta, K Ray.   

Abstract

BACKGROUND: Oculocutaneous albinism (OCA) refers to a group of inherited disorders where the patients have little or no pigment in the eyes, skin and hair. Mutations in genes regulating multi-step melanin biosynthesis are the basis of four 'classical' OCA types with overlapping clinical features. There are a few reports on defects in TYR and a single report on SLC45A2 in Indians affected with OCA but no report on OCA2 (a major locus related to the disease) and TYRP1.
OBJECTIVES: To assess and describe a comprehensive picture of the molecular genetic basis of OCA among Indians with no apparent mutations in TYR.
METHODS: Twenty-four affected pedigrees from 14 different ethnicities were analysed for mutations in OCA2, TYRP1, SLC45A2 and SLC24A5 using the polymerase chain reaction-sequencing approach.
RESULTS: Two splice-site and four missense mutations were detected in OCA2 in seven unrelated pedigrees, including four novel mutations. Haplotype analysis revealed a founder mutation (Ala787Thr) in two unrelated families of the same ethnicity. A patient homozygous for a novel SLC45A2 mutation also harboured a novel OCA2 defect. No mutation was detected in TYRP1 or SLC24A5.
CONCLUSIONS: Our results suggest that an OCA2 gene defect is the second most prevalent type of OCA in India after TYR. The presence of homozygous mutations in the affected pedigrees underscores the lack of intermixing between the affected ethnicities. Direct detection of the genetic lesions prevalent in specific ethnic groups could be used for carrier detection and genetic counselling to contain the disease.
© 2010 The Authors. Journal Compilation © 2010 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20426782     DOI: 10.1111/j.1365-2133.2010.09830.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Analysis of MC1R variants in Indian oculocutaneous albinism patients: highlighting the risk of skin cancer among albinos.

Authors:  Mainak Sengupta; Devroop Sarkar; Maitreye Mondal; Swapan Samanta; Asim Sil; Kunal Ray
Journal:  J Genet       Date:  2013       Impact factor: 1.166

2.  Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.

Authors:  Thomas J Jaworek; Tasleem Kausar; Shannon M Bell; Nabeela Tariq; Muhammad Imran Maqsood; Asma Sohail; Muhmmmad Ali; Furhan Iqbal; Shafqat Rasool; Saima Riazuddin; Rehan S Shaikh; Zubair M Ahmed
Journal:  Orphanet J Rare Dis       Date:  2012-06-26       Impact factor: 4.123

3.  Molecular outcomes, clinical consequences, and genetic diagnosis of Oculocutaneous Albinism in Pakistani population.

Authors:  Mohsin Shahzad; Sairah Yousaf; Yar M Waryah; Hadia Gul; Tasleem Kausar; Nabeela Tariq; Umair Mahmood; Muhammad Ali; Muzammil A Khan; Ali M Waryah; Rehan S Shaikh; Saima Riazuddin; Zubair M Ahmed
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

4.  Genetic Analysis of 28 Chinese Families With Tyrosinase-Positive Oculocutaneous Albinism.

Authors:  Linya Ma; Jianjian Zhu; Jing Wang; Yazhou Huang; Jibo Zhang; Chao Wang; Yuan Zhou; Dan Peng
Journal:  Front Genet       Date:  2021-10-11       Impact factor: 4.599

5.  NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.

Authors:  Yuanyuan Xiao; Cong Zhou; Hanbing Xie; Shuang Huang; Jing Wang; Shanling Liu
Journal:  BMC Genomics       Date:  2022-04-29       Impact factor: 3.969

6.  Delineating Novel and Known Pathogenic Variants in TYR, OCA2 and HPS-1 Genes in Eight Oculocutaneous Albinism (OCA) Pakistani Families.

Authors:  Muhammad Shakil; Abida Akbar; Nazish Mahmood Aisha; Intzar Hussain; Muhammad Ikram Ullah; Muhammad Atif; Haiba Kaul; Ali Amar; Muhammad Zahid Latif; Muhammad Atif Qureshi; Saqib Mahmood
Journal:  Genes (Basel)       Date:  2022-03-12       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.